Acknowledgements This work was supported by funds from Natural Science Foundation of China (22377033, 22377037, 22577038, 82473109), the Science and Technology Program of Guangdong Province (2023B1515120023, 2025A0505080018, 2024A1515013002, 2023A0505050149), Guangdong Basic and Applied Basic Research Foundation (2023B1515040016, 2025A1515012357, 2024A1515013266, 2026B1515020070)
While intravenous delivery of glutathione may be the most efficient route as it can bypass metabolic barriers, oral delivery remains the most practical and accessible route for long-term use due to higher patient compliance [9,17]
No Artificial Additives: The formulation is free from fillers, preservatives, or artificial colors, making it safe for long-term use
"This is going to play out over quarters, not days ask people to take a beat and let us execute." Barclays analyst Emily Field noted last week that oral Wegovy and Foundayo are going for different patient segments, with the former having "injectable-like efficacy" and the latter perhaps being viewed as more of a "starter" GLP-1